ID PK3C3_XENLA Reviewed; 886 AA. AC Q6AZN6; DT 06-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 13-SEP-2004, sequence version 1. DT 27-MAR-2024, entry version 103. DE RecName: Full=Phosphatidylinositol 3-kinase catalytic subunit type 3; DE Short=PI3-kinase type 3; DE Short=PI3K type 3; DE Short=PtdIns-3-kinase type 3; DE EC=2.7.1.137 {ECO:0000250|UniProtKB:Q8NEB9}; DE AltName: Full=Phosphoinositide-3-kinase class 3; GN Name=pik3c3; OS Xenopus laevis (African clawed frog). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus. OX NCBI_TaxID=8355; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Embryo; RG NIH - Xenopus Gene Collection (XGC) project; RL Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalytic subunit of the PI3K complex that mediates formation CC of phosphatidylinositol 3-phosphate; different complex forms are CC believed to play a role in multiple membrane trafficking pathways. CC Involved in the transport of lysosomal enzyme precursors to lysosomes. CC Required for transport from early to late endosomes (By similarity). CC {ECO:0000250|UniProtKB:O88763, ECO:0000250|UniProtKB:Q8NEB9}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a CC 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate) + ADP + CC H(+); Xref=Rhea:RHEA:12709, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:57880, ChEBI:CHEBI:58088, ChEBI:CHEBI:456216; CC EC=2.7.1.137; Evidence={ECO:0000250|UniProtKB:Q8NEB9}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12710; CC Evidence={ECO:0000250|UniProtKB:Q8NEB9}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000250|UniProtKB:Q8NEB9}; CC -!- SUBUNIT: Component of the PI3K (PI3KC3/PI3K-III/class III CC phosphatidylinositol 3-kinase) complex the core of which is composed of CC the catalytic subunit pik3c3, the regulatory subunit pik3r4 and becn1 CC associating with additional regulatory/auxilliary subunits to form CC alternative complex forms. {ECO:0000250|UniProtKB:Q8NEB9}. CC -!- SUBCELLULAR LOCATION: Midbody {ECO:0000250|UniProtKB:Q8NEB9}. CC -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000255|PROSITE- CC ProRule:PRU00880}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC077528; AAH77528.1; -; mRNA. DR RefSeq; NP_001086836.1; NM_001093367.1. DR AlphaFoldDB; Q6AZN6; -. DR SMR; Q6AZN6; -. DR IntAct; Q6AZN6; 1. DR GeneID; 446671; -. DR KEGG; xla:446671; -. DR AGR; Xenbase:XB-GENE-6085232; -. DR CTD; 446671; -. DR Xenbase; XB-GENE-6085232; pik3c3.L. DR OMA; LHKFAQY; -. DR OrthoDB; 10350at2759; -. DR Proteomes; UP000186698; Chromosome 1L. DR Bgee; 446671; Expressed in testis and 19 other cell types or tissues. DR GO; GO:0030496; C:midbody; ISS:UniProtKB. DR GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0032465; P:regulation of cytokinesis; ISS:UniProtKB. DR CDD; cd08397; C2_PI3K_class_III; 1. DR CDD; cd00870; PI3Ka_III; 1. DR CDD; cd00896; PI3Kc_III; 1. DR Gene3D; 2.60.40.150; C2 domain; 1. DR Gene3D; 1.10.1070.11; Phosphatidylinositol 3-/4-kinase, catalytic domain; 1. DR Gene3D; 1.25.40.70; Phosphatidylinositol 3-kinase, accessory domain (PIK); 1. DR InterPro; IPR016024; ARM-type_fold. DR InterPro; IPR035892; C2_domain_sf. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000403; PI3/4_kinase_cat_dom. DR InterPro; IPR036940; PI3/4_kinase_cat_sf. DR InterPro; IPR018936; PI3/4_kinase_CS. DR InterPro; IPR002420; PI3K-type_C2_dom. DR InterPro; IPR001263; PI3K_accessory_dom. DR InterPro; IPR042236; PI3K_accessory_sf. DR InterPro; IPR008290; PI3K_Vps34. DR InterPro; IPR015433; PI_Kinase. DR PANTHER; PTHR10048:SF7; PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3; 1. DR PANTHER; PTHR10048; PHOSPHATIDYLINOSITOL KINASE; 1. DR Pfam; PF00454; PI3_PI4_kinase; 1. DR Pfam; PF00792; PI3K_C2; 1. DR Pfam; PF00613; PI3Ka; 1. DR PIRSF; PIRSF000587; PI3K_Vps34; 1. DR SMART; SM00142; PI3K_C2; 1. DR SMART; SM00145; PI3Ka; 1. DR SMART; SM00146; PI3Kc; 1. DR SUPFAM; SSF48371; ARM repeat; 1. DR SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS51547; C2_PI3K; 1. DR PROSITE; PS00915; PI3_4_KINASE_1; 1. DR PROSITE; PS00916; PI3_4_KINASE_2; 1. DR PROSITE; PS50290; PI3_4_KINASE_3; 1. DR PROSITE; PS51545; PIK_HELICAL; 1. PE 2: Evidence at transcript level; KW ATP-binding; Autophagy; Cell cycle; Cell division; Kinase; KW Lipid metabolism; Manganese; Nucleotide-binding; Reference proteome; KW Transferase. FT CHAIN 1..886 FT /note="Phosphatidylinositol 3-kinase catalytic subunit type FT 3" FT /id="PRO_0000088806" FT DOMAIN 35..184 FT /note="C2 PI3K-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00880" FT DOMAIN 283..519 FT /note="PIK helical" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00878" FT DOMAIN 604..870 FT /note="PI3K/PI4K catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00269" FT REGION 414..464 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 610..616 FT /note="G-loop" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00269" FT REGION 739..747 FT /note="Catalytic loop" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00269" FT REGION 758..779 FT /note="Activation loop" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00269" FT COMPBIAS 424..450 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" SQ SEQUENCE 886 AA; 101157 MW; FBAFB8847FBB60A9 CRC64; MGESDRFCYV YSCDLDISVR LKIGSLEGKR EQKSYKAVLE DPMLKFSGLY QETCSDLYVT CQVFAEGKPL ALPVRTSYKA FSTRWNWNEW LKLPVKYADL PRSAQVALTI WDVYGPGKAI PVGGATVSLF GKYGMFRQGM HDLKVWPNIE ADGSELTKTP GRTNSSASED QMSRLAKLTK AHRQGHMVKV DWLDRLTFRE IEMINESEKR SSNFMYLMVE FPCVKCDEKE YGIVYYEKDG DESTPISTSS EIVRVPDPQM SMENLVEIKH HKLARSLRSG PSDHDLKPNA ATRDQLNIIV SYPPTKQLTS EEQDLVWKFR SYLTSQEKAL TKFLKCVNWD LPQEAKQALE LLGKWKPMDV EDSLELLSSH FTNPTVRRYA VARLQQADDE DLLMYLLQLV QALKYENFED IKSGLEPTKK DSQGPMLESM TTSGINPETD SSQILSNPLP AVSSPAPPSK TKDGLDAETL EQDLCTFLIS RACKNSTLAN YLYWYVIVEC EDQDTQLRDP KTHEMYLNVM RRFSQALLKG DKSVRVMRSL LATQQTFVDR LVHLMKAVQR ESGNRKKKNE RLQALLGDNE KMNLSEFEPI PLPLEPQVKI RGIIPEKATL FKSALMPAKL YFKTEDGGKY PVIFKNGDDL RQDQLILQII SLMDKLLRKE NLDLKLTPYK VLATSTKHGF MQFIQSVPVA EVLATEGSIQ NFFRKYSPSE KGPYGISAEV MDTYVKSCAG YCVITYILGV GDRHLDNLLL TKTGKLFHID FGYILGRDPK PLPPPMKLNK EMVEGMGGTQ SEQYQAFRKQ CYTAFLHLRR YSNLILNLFS LMVDANIPDI ALEPDKTVKK VQDKFRLDLS DEEAVHYMQT LIDDSVNALF AAVVEQIHKF AQYWRR //